Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengchun Wu

Showing results (31-40 of 153) with videos related to

Pageof 16
Sort By:
CNS Neuroscience & Therapeutics|June 30, 2022
Kynurenine pathway metabolites and therapeutic response to olanzapine in female patients with schizophrenia: A longitudinal studyXiaoni Guan, Jing Xu, Meihong Xiu, et al.
Metabolomics : Official Journal of the Metabolomic Society|July 12, 2022
Plasma linoelaidyl carnitine levels positively correlated with symptom improvement in olanzapine-treated first-episode drug-naïve schizophreniaXuan Wang, Meihong Xiu, Keqiang Wang, et al.
Nordic Journal of Psychiatry|December 20, 2021
Increased plasma level of kynurenic acid in drug-free patients with first-episode schizophrenia compared to patients with chronic schizophrenia and healthy controls: preliminary dataWenhua Ding, Fengchun Wu, Sumiao Zhou, et al.
Asian Journal of Psychiatry|September 19, 2024
Abnormal resting-state functional connectivity of the right anterior cingulate cortex in chronic ketamine users and its correlation with cognitive impairmentsJun Zhong, Fengchun Wu, Huawang Wu, et al.
The International Journal of Neuropsychopharmacology|December 10, 2024
Gonadal hormone abnormalities in young patients with first-episode schizophreniaQiang Hu, Jindong Wang, Jing Liang, et al.
Current Neuropharmacology|May 3, 2023
Smoking Affects the Predictive Roles of Antioxidant Enzymes in the Clinical Response to Risperidone in Schizophrenia: A Large-scale Cohort StudyMeihong Xiu, Xiuli Song, Hanlun Yang, et al.
Frontiers in Psychiatry|July 9, 2021
Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life SchizophreniaLijuan Huo, Zhiwei Zheng, Xiaobing Lu, et al.
Human Psychopharmacology|February 14, 2020
Sex differences in the prevalence and clinical correlates of hyperhomocysteinemia in patients with bipolar disorderLi Mu, Yezhe Lin, Xingbing Huang, et al.
BMC Psychiatry|December 5, 2021
Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficitsLijuan Huo, Xiaobing Lu, Fengchun Wu, et al.
Journal of Psychiatric Research|October 10, 2020
Diabetes in late-life schizophrenia: Prevalence, factors, and association with clinical symptomsLijuan Huo, Xiaobing Lu, Fengchun Wu, et al.
Pageof 16

Showing results (31-40 of 153) with videos related to

Sort By:
Pageof 16
CNS Neuroscience & Therapeutics|June 30, 2022
Kynurenine pathway metabolites and therapeutic response to olanzapine in female patients with schizophrenia: A longitudinal studyXiaoni Guan, Jing Xu, Meihong Xiu, et al.
Metabolomics : Official Journal of the Metabolomic Society|July 12, 2022
Plasma linoelaidyl carnitine levels positively correlated with symptom improvement in olanzapine-treated first-episode drug-naïve schizophreniaXuan Wang, Meihong Xiu, Keqiang Wang, et al.
Nordic Journal of Psychiatry|December 20, 2021
Increased plasma level of kynurenic acid in drug-free patients with first-episode schizophrenia compared to patients with chronic schizophrenia and healthy controls: preliminary dataWenhua Ding, Fengchun Wu, Sumiao Zhou, et al.
Asian Journal of Psychiatry|September 19, 2024
Abnormal resting-state functional connectivity of the right anterior cingulate cortex in chronic ketamine users and its correlation with cognitive impairmentsJun Zhong, Fengchun Wu, Huawang Wu, et al.
The International Journal of Neuropsychopharmacology|December 10, 2024
Gonadal hormone abnormalities in young patients with first-episode schizophreniaQiang Hu, Jindong Wang, Jing Liang, et al.
Current Neuropharmacology|May 3, 2023
Smoking Affects the Predictive Roles of Antioxidant Enzymes in the Clinical Response to Risperidone in Schizophrenia: A Large-scale Cohort StudyMeihong Xiu, Xiuli Song, Hanlun Yang, et al.
Frontiers in Psychiatry|July 9, 2021
Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life SchizophreniaLijuan Huo, Zhiwei Zheng, Xiaobing Lu, et al.
Human Psychopharmacology|February 14, 2020
Sex differences in the prevalence and clinical correlates of hyperhomocysteinemia in patients with bipolar disorderLi Mu, Yezhe Lin, Xingbing Huang, et al.
BMC Psychiatry|December 5, 2021
Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficitsLijuan Huo, Xiaobing Lu, Fengchun Wu, et al.
Journal of Psychiatric Research|October 10, 2020
Diabetes in late-life schizophrenia: Prevalence, factors, and association with clinical symptomsLijuan Huo, Xiaobing Lu, Fengchun Wu, et al.
Pageof 16